Bridget A. Quinn

1.4k total citations
24 papers, 965 citations indexed

About

Bridget A. Quinn is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Bridget A. Quinn has authored 24 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Bridget A. Quinn's work include Virus-based gene therapy research (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and CAR-T cell therapy research (5 papers). Bridget A. Quinn is often cited by papers focused on Virus-based gene therapy research (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and CAR-T cell therapy research (5 papers). Bridget A. Quinn collaborates with scholars based in United States, India and Jordan. Bridget A. Quinn's co-authors include Paul B. Fisher, Devanand Sarkar, Swadesh K. Das, Maurizio Pellecchia, Rupesh Dash, Luni Emdad, Xiang‐Yang Wang, John C. Reed, Paul Dent and Emma C. Fields and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Bridget A. Quinn

24 papers receiving 953 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bridget A. Quinn 454 408 184 168 119 24 965
Robert Kubiak 553 1.2× 206 0.5× 127 0.7× 144 0.9× 154 1.3× 77 1.1k
Gary L. Goldberg 416 0.9× 303 0.7× 103 0.6× 81 0.5× 92 0.8× 33 867
Danhui Weng 926 2.0× 492 1.2× 147 0.8× 160 1.0× 97 0.8× 41 1.5k
H. Meden 355 0.8× 492 1.2× 118 0.6× 96 0.6× 51 0.4× 68 1.0k
Masafumi Kudoh 654 1.4× 260 0.6× 185 1.0× 119 0.7× 50 0.4× 28 1.1k
Meilan Liu 995 2.2× 575 1.4× 99 0.5× 195 1.2× 75 0.6× 46 1.6k
Martina Rahmeh 476 1.0× 677 1.7× 57 0.3× 96 0.6× 92 0.8× 22 1.2k
Verena Materna 552 1.2× 632 1.5× 109 0.6× 96 0.6× 36 0.3× 33 1.1k
Jaulang Hwang 594 1.3× 388 1.0× 43 0.2× 145 0.9× 69 0.6× 34 1.0k
Rudi Bao 1.0k 2.2× 449 1.1× 160 0.9× 122 0.7× 30 0.3× 19 1.5k

Countries citing papers authored by Bridget A. Quinn

Since Specialization
Citations

This map shows the geographic impact of Bridget A. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget A. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget A. Quinn more than expected).

Fields of papers citing papers by Bridget A. Quinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget A. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget A. Quinn. The network helps show where Bridget A. Quinn may publish in the future.

Co-authorship network of co-authors of Bridget A. Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget A. Quinn. A scholar is included among the top collaborators of Bridget A. Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget A. Quinn. Bridget A. Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, Bridget A., et al.. (2023). Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer. Brachytherapy. 22(3). 334–342. 9 indexed citations
2.
Fields, Emma C., et al.. (2019). The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation. Brachytherapy. 18(6). 763–770. 11 indexed citations
3.
Quinn, Bridget A., et al.. (2018). Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 18(1). 29–37. 93 indexed citations
4.
Quinn, Bridget A., et al.. (2017). Increasing Age Predicts Poor Cervical Cancer Prognosis With Subsequent Effect on Treatment and Overall Survival. International Journal of Radiation Oncology*Biology*Physics. 99(2). E308–E308. 2 indexed citations
5.
Beckta, Jason M., Wen Wan, Bridget A. Quinn, Emma C. Fields, & Timothy P. Kegelman. (2016). Socioeconomic Disparities in Cervical Cancer Patients Presenting to a Tertiary Care Facility. International Journal of Radiation Oncology*Biology*Physics. 96(2). E301–E301. 3 indexed citations
6.
Quinn, Bridget A., Rupesh Dash, Siddik Sarkar, et al.. (2015). Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. Cancer Research. 75(11). 2305–2315. 34 indexed citations
7.
Wu, Bainan, Si Wang, Surya K. De, et al.. (2015). Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells. Chemistry & Biology. 22(7). 876–887. 33 indexed citations
8.
Quinn, Bridget A., Timothy P. Kegelman, Praveen Bhoopathi, et al.. (2015). The Quest for an Effective Treatment for an Intractable Cancer. Advances in cancer research. 127. 283–306. 8 indexed citations
9.
Bhoopathi, Praveen, Bridget A. Quinn, Qin Gui, et al.. (2014). Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid. Cancer Research. 74(21). 6224–6235. 34 indexed citations
10.
Sarkar, Siddik, Belal Azab, Bridget A. Quinn, et al.. (2014). Chemoprevention Gene Therapy (CGT) of Pancreatic Cancer Using Perillyl Alcohol and a Novel Chimeric Serotype Cancer Terminator Virus. Current Molecular Medicine. 14(1). 125–140. 17 indexed citations
11.
Sarkar, Siddik, Bridget A. Quinn, Xue‐Ning Shen, et al.. (2014). Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach. Molecular Pharmacology. 87(2). 286–295. 8 indexed citations
12.
Quinn, Bridget A.. (2014). Novel Therapeutic Strategies for Pancreatic Cancer. VCU Scholars Compass (Virginia Commonwealth University). 1 indexed citations
13.
Azab, Belal, Rupesh Dash, Swadesh K. Das, et al.. (2013). Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV). Journal of Cellular Physiology. 229(1). n/a–n/a. 22 indexed citations
14.
Thomas, Shibu, Bridget A. Quinn, Swadesh K. Das, et al.. (2012). Targeting the Bcl-2 family for cancer therapy. Expert Opinion on Therapeutic Targets. 17(1). 61–75. 218 indexed citations
15.
Dash, Rupesh, Belal Azab, Bridget A. Quinn, et al.. (2011). Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicity. Proceedings of the National Academy of Sciences. 108(21). 8785–8790. 101 indexed citations
17.
Dash, Rupesh, Sujit K. Bhutia, Belal Azab, et al.. (2010). mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine & Growth Factor Reviews. 21(5). 381–391. 91 indexed citations
18.
Quinn, Bridget A., et al.. (2010). Development of a syngeneic mouse model of epithelial ovarian cancer. Journal of Ovarian Research. 3(1). 24–24. 38 indexed citations
19.
Quinn, Bridget A., Tiffany Brake, Hua Xiang, et al.. (2009). Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53. PLoS ONE. 4(12). e8404–e8404. 38 indexed citations
20.
Hensley, Harvey H., Bridget A. Quinn, Ronald L. Wolf, et al.. (2007). Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biology & Therapy. 6(11). 1717–1725. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026